Cargando…

Effect of liraglutide on atherosclerosis in patients with impaired glucose tolerance: A double‑blind, randomized controlled clinical trial

Glucagon-like peptide-1 receptor agonist liraglutide may have beneficial effects on atherosclerosis development in impaired glucose tolerance (IGT). To the best of our knowledge, however, little conclusive evidence from clinical trials has been presented. The present study aimed to investigate the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Liping, Yuan, Yuhong, Li, Yongmei, Rao, Xiaopang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160922/ https://www.ncbi.nlm.nih.gov/pubmed/37153886 http://dx.doi.org/10.3892/etm.2023.11948

Ejemplares similares

Effects of liraglutide on extraglycemic inflammatory markers and renal hemodynamic parameters in diabetic kidney disease (DKD)
por: Song, Wenjuan, et al.
Publicado: (2023)

Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance
por: Simanenkova, Anna, et al.
Publicado: (2021)

Efficacy and Safety of a Biosimilar Liraglutide (Melitide(®)) Versus the Reference Liraglutide (Victoza(®)) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial
por: Esteghamati, Alireza, et al.
Publicado: (2023)

Effect of ginger on the blood glucose level of women with gestational diabetes mellitus (GDM) with impaired glucose tolerance test (GTT): a randomized double-blind placebo-controlled trial
por: Hajimoosayi, Fariba, et al.
Publicado: (2020)

Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA‐SWITCH): a randomized, double‐blind, double‐dummy, active‐controlled 26‐week trial
por: Bailey, T. S., et al.
Publicado: (2016)

Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics
por: Mastrandrea, Lucy D., et al.
Publicado: (2019)

Hypoglycemia Assessed by Continuous Glucose Monitoring Is Associated with Preclinical Atherosclerosis in Individuals with Impaired Glucose Tolerance
por: Castaldo, Ersilia, et al.
Publicado: (2011)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial
por: Leal, José, et al.
Publicado: (2022)

Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance
por: Guo, Qiuyue, et al.
Publicado: (2022)

Liraglutide Lowers Endothelial Vascular Cell Adhesion Molecule-1 in Murine Atherosclerosis Independent of Glucose Levels
por: Punjabi, Mukesh, et al.
Publicado: (2022)

Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36‐week, randomized, double‐blind, parallel‐group trial
por: Seino, Yutaka, et al.
Publicado: (2016)

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
por: Zhao, Xu, et al.
Publicado: (2019)

Machine learning to predict rapid progression of carotid atherosclerosis in patients with impaired glucose tolerance
por: Hu, Xia, et al.
Publicado: (2016)

Effect of liraglutide on physical performance in type 2 diabetes (LIPER2): A randomised, double-blind, controlled trial
por: Wägner, Ana María, et al.
Publicado: (2016)

Valsartan Improves Adipose Tissue Function in Humans with Impaired Glucose Metabolism: A Randomized Placebo-Controlled Double-Blind Trial
por: Goossens, Gijs H., et al.
Publicado: (2012)

A New Approach to Overcome Insulin Resistance in Patients with Impaired Glucose Tolerance: The Results of a Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety of Subetta
por: Mkrtumyan, Ashot, et al.
Publicado: (2022)

Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
por: Oh, Mi-Ra, et al.
Publicado: (2014)

Effect of Liraglutide on Arterial Inflammation Assessed as [(18)F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Ripa, Rasmus S., et al.
Publicado: (2021)

The efficacy and safety of probiotics intervention in preventing conversion of impaired glucose tolerance to diabetes: study protocol for a randomized, double-blinded, placebo controlled trial of the Probiotics Prevention Diabetes Programme (PPDP)
por: Yan, Qun, et al.
Publicado: (2015)

Evaluation of a Standardized Extract from Morus alba against α-Glucosidase Inhibitory Effect and Postprandial Antihyperglycemic in Patients with Impaired Glucose Tolerance: A Randomized Double-Blind Clinical Trial
por: Hwang, Seung Hwan, et al.
Publicado: (2016)

Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Moon, Heui-Soo, et al.
Publicado: (2010)

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
por: Lean, M E J, et al.
Publicado: (2014)

Safety and tolerability of virucidal hand rubs: a randomized, double-blind, cross-over trial
por: Conrad, A, et al.
Publicado: (2011)

Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial
por: Grant, Suzanne J, et al.
Publicado: (2013)

Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product
por: Cicero, Arrigo Francesco Giuseppe, et al.
Publicado: (2017)

Effect of acacia polyphenol on glucose homeostasis in subjects with impaired glucose tolerance: A randomized multicenter feeding trial
por: OGAWA, SOSUKE, et al.
Publicado: (2013)

Acupuncture for Impaired Glucose Tolerance in People With Obesity: A Protocol for a Multicenter Randomized Controlled Trial
por: Yan, Yan, et al.
Publicado: (2022)

SAT-099 Liraglutide 3.0 mg as an Adjunct to Intensive Behavior Therapy in Individuals with Obesity: SCALE IBT 56-Week Randomized, Double-Blind, Placebo-Controlled Trial
por: Wadden, Thomas, et al.
Publicado: (2019)

Safety and Tolerance of a Novel Anti-Regurgitation Formula: A Double-Blind, Randomized, Controlled Trial
por: Bellaiche, Marc, et al.
Publicado: (2021)

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol(®) on glycemic control of subjects with impaired fasting glucose
por: Evans, Malkanthi, et al.
Publicado: (2015)

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial
por: Blonde, Lawrence, et al.
Publicado: (2020)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
por: Armstrong, Matthew J, et al.
Publicado: (2013)

Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial
por: Myat, Aung, et al.
Publicado: (2021)

Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
por: Tönjes, Anke, et al.
Publicado: (2010)

Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
por: Bisgaard, Line S., et al.
Publicado: (2016)

The Role of Vaspin in the Development of Metabolic and Glucose Tolerance Disorders and Atherosclerosis
por: Dimova, Rumyana, et al.
Publicado: (2015)

Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double‐Blind, Randomized, Placebo‐Controlled Trial
por: Paiman, Elisabeth H.M., et al.
Publicado: (2019)

Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study
por: Vicknasingam, Balasingam, et al.
Publicado: (2020)

Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double–blind, multicentric trial
por: Shah, Sandip, et al.
Publicado: (2011)

Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial
por: Johnston, William H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ilftj5eoprbbg7vupqq3rohchc